United States

Profile: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

25 Sep 2017
Change (% chg)

$0.72 (+2.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to enable optimal treatment, or assess a patient's risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Its molecular diagnostic tests include myRisk Hereditary Cancer, BRACAnalysis CDx and COLARIS.

Company Address

Myriad Genetics Inc

320 S Wakara Way
SALT LAKE CITY   UT   84108-1214
P: +1801.5843600
F: +1801.5843640

Company Web Links